173 related articles for article (PubMed ID: 18660695)
1. Premature ovarian failure: predictability of intermittent ovarian function and response to ovulation induction agents.
Bidet M; Bachelot A; Touraine P
Curr Opin Obstet Gynecol; 2008 Aug; 20(4):416-20. PubMed ID: 18660695
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous pregnancies despite failed attempts at ovulation induction in a woman with latrogenic premature ovarian failure.
Menashe Y; Pearlstone AC; Surrey ES
J Reprod Med; 1996 Mar; 41(3):207-10. PubMed ID: 8778425
[TBL] [Abstract][Full Text] [Related]
3. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome.
Broer SL; Mol B; Dólleman M; Fauser BC; Broekmans FJ
Curr Opin Obstet Gynecol; 2010 Jun; 22(3):193-201. PubMed ID: 20407372
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of different markers of the ovarian reserve in patients presenting with premature ovarian failure.
Massin N; Méduri G; Bachelot A; Misrahi M; Kuttenn F; Touraine P
Mol Cell Endocrinol; 2008 Jan; 282(1-2):95-100. PubMed ID: 18191888
[TBL] [Abstract][Full Text] [Related]
5. [Premature ovarian failure: etiopathogenic evaluation and therapeutic possibilities].
Battista T; Montanino Oliva M; Montanino G
Minerva Ginecol; 1994 Apr; 46(4):135-45. PubMed ID: 8065585
[TBL] [Abstract][Full Text] [Related]
6. Premature ovarian failure and pregnancy.
Vandborg M; Lauszus FF
Arch Gynecol Obstet; 2006 Mar; 273(6):387-8. PubMed ID: 16328395
[TBL] [Abstract][Full Text] [Related]
7. [Premature ovarian failure: which protocols?].
Merviel P; Lourdel E; Boulard V; Cabry R; Claeys C; Oliéric MF; Sanguinet P; Brasseur F; Henri I; Copin H
Gynecol Obstet Fertil; 2008 Sep; 36(9):872-81. PubMed ID: 18703373
[TBL] [Abstract][Full Text] [Related]
8. [Anti-Müllerian hormone--its role in management of involuntary infertility].
Kalra GS
Tidsskr Nor Laegeforen; 2009 Feb; 129(5):409-11. PubMed ID: 19247400
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous twin pregnancy in premature ovarian failure.
Anna Liza R; Alik RZ; Ahmad Murad Z; Ghazali I
Med J Malaysia; 2008 Aug; 63(3):263-4. PubMed ID: 19248707
[TBL] [Abstract][Full Text] [Related]
10. Anti-müllerian hormone as a marker of ovarian function in women after chemotherapy and radiotherapy for haematological malignancies.
Lie Fong S; Lugtenburg PJ; Schipper I; Themmen AP; de Jong FH; Sonneveld P; Laven JS
Hum Reprod; 2008 Mar; 23(3):674-8. PubMed ID: 18216040
[TBL] [Abstract][Full Text] [Related]
11. A pilot study of premature ovarian senescence: II. Different genotype and phenotype for genetic and autoimmune etiologies.
Gleicher N; Weghofer A; Barad DH
Fertil Steril; 2009 May; 91(5):1707-11. PubMed ID: 18384784
[TBL] [Abstract][Full Text] [Related]
12. Predictors of ovarian response: progress towards individualized treatment in ovulation induction and ovarian stimulation.
Fauser BC; Diedrich K; Devroey P;
Hum Reprod Update; 2008; 14(1):1-14. PubMed ID: 18006561
[TBL] [Abstract][Full Text] [Related]
13. Pregnancy in classic galactosemia despite undetectable anti-Müllerian hormone.
Gubbels CS; Kuppens SM; Bakker JA; Konings CJ; Wodzig KW; de Sain-van der Velden MG; Menheere PP; Rubio-Gozalbo ME
Fertil Steril; 2009 Apr; 91(4):1293.e13-6. PubMed ID: 19200962
[TBL] [Abstract][Full Text] [Related]
14. Anti-Müllerian hormone-based approach to controlled ovarian stimulation for assisted conception.
Nelson SM; Yates RW; Lyall H; Jamieson M; Traynor I; Gaudoin M; Mitchell P; Ambrose P; Fleming R
Hum Reprod; 2009 Apr; 24(4):867-75. PubMed ID: 19136673
[TBL] [Abstract][Full Text] [Related]
15. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
[TBL] [Abstract][Full Text] [Related]
16. An estrogen treatment may reverse a premature ovarian failure.
Neves-E-Castro M
Fertil Steril; 2009 Apr; 91(4):e1; author reply e2. PubMed ID: 19230878
[No Abstract] [Full Text] [Related]
17. Assessment of ovarian reserve with anti-Müllerian hormone: a comparison of the predictive value of anti-Müllerian hormone, follicle-stimulating hormone, inhibin B, and age.
Riggs RM; Duran EH; Baker MW; Kimble TD; Hobeika E; Yin L; Matos-Bodden L; Leader B; Stadtmauer L
Am J Obstet Gynecol; 2008 Aug; 199(2):202.e1-8. PubMed ID: 18674663
[TBL] [Abstract][Full Text] [Related]
18. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
19. Twin gestation two years after the diagnosis of premature ovarian failure in a woman on hormone replacement therapy. A case report.
Fernandes AM; Arruda Mde S; Bedone AJ
J Reprod Med; 2002 Jun; 47(6):504-6. PubMed ID: 12092022
[TBL] [Abstract][Full Text] [Related]
20. Poor responder protocols for in-vitro fertilization: options and results.
Loutradis D; Vomvolaki E; Drakakis P
Curr Opin Obstet Gynecol; 2008 Aug; 20(4):374-8. PubMed ID: 18660689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
